ICD-10 Coding for Ductal Carcinoma In Situ (DCIS) of the Breast(D05.1, D05.12, D05.1I)
Learn about ICD-10 coding for ductal carcinoma in situ (DCIS) of the breast, including primary and ancillary codes, documentation requirements, and common coding pitfalls.
Complete code families applicable to Ductal Carcinoma In Situ (DCIS) of the Breast
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| D05.1 | Intraductal carcinoma in situ | Use when DCIS is confirmed by biopsy without invasive components. |
|
| Z85.3 | Personal history of malignant neoplasm of breast | Use for patients with a history of DCIS after complete excision. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutDuctal Carcinoma In Situ (DCIS) of the Breast
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Ductal Carcinoma In Situ (DCIS) of the Breast.
Using Z85.3 during active treatment
Impact
Clinical: Misrepresentation of patient's current treatment status., Regulatory: Potential audit issues due to incorrect coding., Financial: Inaccurate billing and potential claim denials.
Mitigation
Verify treatment status before coding, Review pathology reports for residual disease
Coding suspected DCIS as confirmed
Impact
Reimbursement: Incorrect reimbursement due to inappropriate code usage., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate clinical data affecting patient records.
Mitigation
Use symptom codes until biopsy confirms DCIS.
Mismatch between imaging and pathology
Impact
Discrepancies between imaging findings and pathology reports can trigger audits.
Mitigation
Ensure all findings are reconciled and documented accurately.